⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026
Investdesk

NSE

Aarti Drugs LimitedAARTIDRUGS

Aarti Drugs Limited is an Indian pharmaceutical company focused on manufacturing and marketing of generic drugs.

Key productsGeneric drugs, APIs (Active Pharmaceutical Ingredients)
GeographyIndia, Export markets in Southeast Asia, Middle East
CompetitorsDr Reddy's Laboratories, Cipla

AI-generated overview — verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 · tilt Neutral

Next corporate action

Interim Dividend - Rs 2 Per Share

ex 2026-02-09

Competitive landscape — the read

vs most-traded names · 1Y
1M3M6M1Y2YAll
Institutional money is backing ATALREAL hardest (+₹15.1 Cr net). AARTIDRUGS ranks #4 of 7 on flow (net buying +₹0 Cr).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+₹15.1 Cr267————
2MOBIKWIK+₹5.2 Cr355————
3MTNL+₹0.1 Cr26————
4AARTIDRUGSThis——————
5GATECH−₹0.3 Cr77————
6IRMENERGY−₹2.2 Cr356————
7QUADFUTURE−₹7.9 Cr177————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Strengths

  • • [object Object]
  • • [object Object]

Weaknesses

  • • [object Object]
  • • [object Object]

Opportunities

  • • [object Object]
  • • [object Object]

Threats

  • • [object Object]
  • • [object Object]

AI-generated from our data — verify before relying on it.

Timeline — AARTIDRUGS day by day

1M3M6M1Y2YAll
  1. 2026-06-16FilingAarti Drugs Limited has informed the Exchange about Schedule of meetInvestor Call
  2. 2026-06-16FilingAarti Drugs Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
  3. 2026-02-09ActionInterim Dividend - Rs 2 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

Bulk & block deals

1M3M6M1Y2YAll

No bulk/block deals for AARTIDRUGS in this window.

Results & transcripts

Financial results

None yet.

News & chatter on AARTIDRUGS

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.